PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Independent Bo

18 Aug 2008 07:00

RNS Number : 4921B
Phorm Inc
18 August 2008
 



Phorm, Inc. ("Phorm" or the "Company") 

Phorm Elects Steven J. Heyer as Independent Board Chairman 

Phorm (AIM: PHRM and PHRX), the advertising technology company, today announces the election of Non-Executive Director, Steven J. Heyer, as Board Chairman. Kent Ertugrul will continue to lead the Company as Chief Executive Officer, driving the implementation of Phorm's business strategy and technology. The appointment takes effect immediately and will strengthen Phorm's corporate governance while providing a solid leadership platform for future growth as the Company moves to the next stage of its development.

Mr. Heyer, aged 56, joined the Phorm Board in October 2007 and brings with him over three decades of global management experience, strong marketing skills and a deep knowledge of the development of brands. He is the Co-Chairman and CEO of Fathom Studios, a CG animation company, and the former CEO of Starwood Hotels & Resorts Worldwide; President and COO of Coca-Cola Company; President and COO of Turner Broadcasting System, Inc.; and President and COO of Young and Rubicam, Inc. Mr. Heyer is also a member of the Board of Directors of Lazard Group, Omnicare Inc., Vitrue Inc., a social networking company, NCAA, and Special Olympics.

Kent Ertugrul, Chief Executive Officer of Phorm, Inc., said: "Splitting the role of Chairman and Chief Executive will enable me to focus more of my time and efforts on driving our vision. I am very pleased to be working even more closely with Steve. Steve's broad business experience, commercial acumen and deep knowledge of the media, advertising and ISP industries will continue to prove invaluable to Phorm going forward. Our collaboration has proved very effective in implementing our vision for Phorm. We have the right strategy in place and great momentum and I am confident this change will further strengthen our business."

Steven Heyer commented: "Kent and the management team have made very significant progress in executing the Company's strategy, developing Phorm's proprietary technology platform and building strong relationships with ISPs, advertisers and publishers. Our strategy is sound and, as Chairman, I look forward to working even more closely with Kent, our team and our partners. We are all very enthusiastic about Phorm's future growth potential. The Board is committed to positioning the Company for success and delivering value to our shareholders."

For Phorm Enquiries:

Lynne Millar (Chief Financial Officer) +44 20 7638 9571

Citigate Dewe Rogerson +44 20 7638 9571

Simon Rigby

Justin Griffiths

Canaccord Adams Limited +44 20 7050 6500

(Nominated Advisor)

Mark Williams

Andrew Chubb

About Phorm: 

Phorm is an innovative technology company specialising in delivering behaviourally and contextually targeted advertising while preserving users' personal privacy and security. 

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

Phorm is a Delaware corporation, with offices in New York, London and Moscow. The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 100 employees.

For more information, please visit: www.phorm.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPRMJTMMMBTLP
Date   Source Headline
5th Jan 20107:00 amRNSTransfer of shares
17th Dec 200911:51 amRNSPurchase of Shares and Total Voting Rights
4th Nov 20092:18 pmRNSNotification of major interest in shares
2nd Nov 200912:42 pmRNSResult of AGM
6th Oct 20092:07 pmRNSNotice of AGM
2nd Oct 20097:00 amRNSNotification of major interest in shares
21st Sep 20097:00 amRNSInterim results
14th Sep 20098:57 amRNSNotification of Results
5th Aug 20097:00 amRNSTransfer of Shares
8th Jul 20098:27 amRNSOperational Update
6th Jul 20099:22 amRNSStatement on UK operations
30th Jun 20097:13 amRNSAnnual Accounts
19th Jun 200911:06 amRNSTotal Voting Rights
18th Jun 20097:00 amRNSFinal Results
10th Jun 20097:00 amRNSPlacing to raise ?15 million
3rd Jun 200911:00 amRNSPhorm announces Webwise Discover
21st May 20097:00 amRNSKorean Market Trial
27th Apr 200910:31 amRNSStatement re Apology from "New Media Age" Magazine
14th Apr 20096:23 pmRNSPhorm Statement re EU Commission
9th Apr 20093:57 pmRNSAIM Block Admission
30th Mar 20097:00 amRNSKorean Market Trial
26th Mar 20097:03 amRNSGrant of Options
19th Mar 20091:31 pmRNSGrant of Options
18th Mar 20097:00 amRNSChange of Broker
13th Mar 20095:03 pmRNSShare Issue - Replacement
13th Mar 20092:46 pmRNSShare Issue
11th Mar 20099:49 amRNSAnnouncement of Appointments
4th Mar 20093:18 pmRNSCity Events Wire
17th Dec 20085:52 pmRNSManagement Appointments
15th Dec 20087:00 amRNSBT Trial Update
1st Dec 20087:00 amRNSPhorm Announces Board Changes
5th Nov 20087:46 amRNSDisclosure of Share Sale
22nd Oct 20085:14 pmRNSGrant of options
14th Oct 200810:15 amRNSCancellation of admission of shares
30th Sep 20087:00 amRNSInterim Results
29th Sep 20087:00 amRNSCommencement of BT Trial
22nd Sep 200811:15 amRNSResponse to Statement by BERR
4th Sep 20087:00 amRNSPhorm Update
18th Aug 20087:00 amRNSAppointment of Independent Bo
24th Jun 20087:00 amRNSTransfer of Shares
14th May 20084:45 pmRNSExercise of Options
14th May 200812:55 pmRNSAnnual Report and Accounts
10th Apr 20087:01 amRNSFinal Results
4th Apr 20084:23 pmRNSNotification of Holding
4th Apr 20084:16 pmRNSNotification Of Shareholding
4th Apr 200812:11 pmRNSNotification Of Shareholding
19th Mar 20087:01 amRNSIssue of Equity
13th Mar 200811:32 amRNSResult of Stockholder Meeting
11th Mar 20087:02 amRNSRe Share Price Movement
28th Feb 20085:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.